GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Choong Ang Vaccine Laboratory Co Ltd (XKRX:072020) » Definitions » Cash-to-Debt

Choong Ang Vaccine Laboratory Co (XKRX:072020) Cash-to-Debt : 3.30 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Choong Ang Vaccine Laboratory Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Choong Ang Vaccine Laboratory Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 3.30.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Choong Ang Vaccine Laboratory Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Choong Ang Vaccine Laboratory Co's Cash-to-Debt or its related term are showing as below:

XKRX:072020' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.43   Med: 2.72   Max: 34.73
Current: 3.3

During the past 13 years, Choong Ang Vaccine Laboratory Co's highest Cash to Debt Ratio was 34.73. The lowest was 1.43. And the median was 2.72.

XKRX:072020's Cash-to-Debt is ranked better than
66.89% of 1051 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs XKRX:072020: 3.30

Choong Ang Vaccine Laboratory Co Cash-to-Debt Historical Data

The historical data trend for Choong Ang Vaccine Laboratory Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Choong Ang Vaccine Laboratory Co Cash-to-Debt Chart

Choong Ang Vaccine Laboratory Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.63 2.22 1.81 1.43 2.48

Choong Ang Vaccine Laboratory Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 1.94 1.81 2.48 3.30

Competitive Comparison of Choong Ang Vaccine Laboratory Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Choong Ang Vaccine Laboratory Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Choong Ang Vaccine Laboratory Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Choong Ang Vaccine Laboratory Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Choong Ang Vaccine Laboratory Co's Cash-to-Debt falls into.



Choong Ang Vaccine Laboratory Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Choong Ang Vaccine Laboratory Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Choong Ang Vaccine Laboratory Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Choong Ang Vaccine Laboratory Co  (XKRX:072020) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Choong Ang Vaccine Laboratory Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Choong Ang Vaccine Laboratory Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Choong Ang Vaccine Laboratory Co (XKRX:072020) Business Description

Traded in Other Exchanges
N/A
Address
1476-37 Yongsan-dong, Yuseong-gu, Daejeon, KOR, 305-348
Choong Ang Vaccine Laboratory Co., Ltd. manufactures and markets vaccines for animals. The company specialized in vaccines for animals and is the largest one in Korea. The company has a solid financial structure.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Headlines

No Headlines